ICE (ifosfamide, carboplatin, etoposide) with or without bortezomib in patients with relapsed/refractory Hodgkin lymphoma: results of a randomized phase II trial

Spremljeno u:
Bibliografski detalji
Izdano u:Leuk Lymphoma
Glavni autori: Karuturi, Meghan, Younes, Anas, Fayad, Luis, Kwak, Larry, Pro, Barbara, Shah, Jatin, Oki, Yasuhiro, Simien, Rinata, Liboon, Mary Joy, Hutto, Toni, Feng, Lei, Horowitz, Sandra, Nieto, Yago, Anderlini, Paolo, Alousi, Amin, Popat, Uday, Medeiros, L. Jeffrey, Miranda, Roberto, Fanale, Michelle
Format: Artigo
Jezik:Inglês
Izdano: 2015
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5215977/
https://ncbi.nlm.nih.gov/pubmed/25804933
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/10428194.2015.1032966
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items